MENU
REGN
AS OF
Feb 4, 04:59 PM (EDT)
Price
$775.20
Change
+$16.02 (+2.11%)
Capitalization
79.79B
85 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
REGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Regeneron Pharmaceuticals (REGN) Earnings Date & Reports

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

REGN is expected to report earnings to fall 13.72% to $9.87 per share on April 30

Regeneron Pharmaceuticals REGN Stock Earnings Reports
Q1'26
Est.
$9.87
Q4'25
Beat
by $0.92
Q3'25
Beat
by $2.19
Q2'25
Beat
by $4.39
Q1'25
Missed
by $0.26
The last earnings report on January 30 showed earnings per share of $11.44, beating the estimate of $10.52. With 85.68K shares outstanding, the current market capitalization sits at 79.79B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
REGN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. REGN showed earnings on January 30, 2026. You can read more about the earnings report here.
View AI-Driven Trading for REGN
A.I. Advisor
published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com